The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.

ABSTRACT:

Background

The ABO blood group is reported to be associated with the incidence and patient survival for several types of malignancies. We conducted a retrospective study to evaluate the prognostic significance of the ABO blood group in patients with resected non-small cell lung cancer (NSCLC).

Methods

A total of 333 patients (218 men and 115 women) with resected NSCLC were included in this study. In addition to age, sex, smoking status, preoperative serum carcinoembryonic antigen (CEA) level, operative procedure, histology of tumors, pathological stage (p-stage), and adjuvant therapy, the association between the ABO blood group and survival was explored.

Results

The 5-year overall and disease-free survival rates were 83.0% and 71.6% for blood group O, 67.2% and 62.3%

SUBMITTER: Fukumoto K 

PROVIDER: S-EPMC4310871 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature